A
APT Medical Inc
SSE:688617
APT Medical Inc
SSE:688617
Price:
402.92
CNY
-2.89%
Market Closed
Market Cap:
39.1B
CNY
Balance Sheet
Balance Sheet Decomposition
APT Medical Inc
APT Medical Inc
| Current Assets | 1.5B |
| Cash & Short-Term Investments | 1B |
| Receivables | 61.2m |
| Other Current Assets | 401.2m |
| Non-Current Assets | 1.3B |
| Long-Term Investments | 176.8m |
| PP&E | 534.1m |
| Intangibles | 128.3m |
| Other Non-Current Assets | 430m |
Balance Sheet
APT Medical Inc
APT Medical Inc
Currency: CNY
Millions
Annual
| Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
79
|
91
|
74
|
120
|
310
|
249
|
1 276
|
|
| Cash |
0
|
0
|
73
|
0
|
0
|
249
|
1 276
|
|
| Cash Equivalents |
79
|
91
|
0
|
120
|
310
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
914
|
881
|
60
|
|
| Total Receivables |
34
|
30
|
52
|
50
|
48
|
61
|
51
|
|
| Accounts Receivables |
30
|
25
|
47
|
44
|
34
|
47
|
41
|
|
| Other Receivables |
4
|
5
|
4
|
6
|
14
|
14
|
9
|
|
| Inventory |
44
|
80
|
143
|
145
|
263
|
338
|
328
|
|
| Other Current Assets |
3
|
6
|
7
|
35
|
19
|
28
|
41
|
|
| Total Current Assets |
160
|
207
|
274
|
350
|
1 553
|
1 557
|
1 756
|
|
| PP&E Net |
75
|
104
|
142
|
160
|
259
|
320
|
464
|
|
| PP&E Gross |
75
|
104
|
142
|
160
|
259
|
320
|
464
|
|
| Accumulated Depreciation |
38
|
45
|
57
|
74
|
108
|
161
|
204
|
|
| Intangible Assets |
1
|
1
|
104
|
33
|
32
|
39
|
83
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
48
|
|
| Long-Term Investments |
15
|
13
|
13
|
33
|
121
|
243
|
160
|
|
| Other Long-Term Assets |
2
|
1
|
27
|
13
|
48
|
67
|
62
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
48
|
|
| Total Assets |
253
N/A
|
326
+29%
|
561
+72%
|
589
+5%
|
2 013
+242%
|
2 226
+11%
|
2 573
+16%
|
|
| Liabilities | ||||||||
| Accounts Payable |
6
|
7
|
11
|
8
|
21
|
41
|
43
|
|
| Accrued Liabilities |
15
|
23
|
36
|
47
|
81
|
98
|
133
|
|
| Short-Term Debt |
1
|
11
|
34
|
11
|
16
|
30
|
70
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
5
|
14
|
14
|
11
|
|
| Other Current Liabilities |
12
|
8
|
21
|
39
|
63
|
229
|
331
|
|
| Total Current Liabilities |
34
|
49
|
102
|
109
|
195
|
412
|
588
|
|
| Long-Term Debt |
0
|
0
|
104
|
24
|
17
|
9
|
9
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
3
|
7
|
5
|
|
| Minority Interest |
0
|
1
|
4
|
10
|
13
|
28
|
55
|
|
| Other Liabilities |
5
|
7
|
10
|
6
|
7
|
7
|
9
|
|
| Total Liabilities |
39
N/A
|
56
+45%
|
211
+278%
|
128
-39%
|
235
+83%
|
463
+97%
|
666
+44%
|
|
| Equity | ||||||||
| Common Stock |
29
|
29
|
50
|
50
|
67
|
67
|
67
|
|
| Retained Earnings |
110
|
132
|
140
|
251
|
426
|
717
|
1 141
|
|
| Additional Paid In Capital |
75
|
109
|
160
|
160
|
1 268
|
1 013
|
724
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
27
|
34
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
60
|
60
|
|
| Other Equity |
0
|
0
|
0
|
0
|
18
|
0
|
1
|
|
| Total Equity |
214
N/A
|
270
+26%
|
350
+30%
|
460
+32%
|
1 778
+286%
|
1 763
-1%
|
1 907
+8%
|
|
| Total Liabilities & Equity |
253
N/A
|
326
+29%
|
561
+72%
|
589
+5%
|
2 013
+242%
|
2 226
+11%
|
2 573
+16%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
67
|
67
|
67
|
67
|
67
|
96
|
96
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
